𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer

✍ Scribed by Dae Ho Lee; Sang-We Kim; Cheolwon Suh; Jung-Shin Lee; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park; Im-Il Na; Jae Cheol Lee; Baek-Yeol Ryoo; Sung Hyun Yang

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
136 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Gemcitabine, paclitaxel, and cisplatin a
Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma : A phase II multicenter study
✍ Filippo De Marinis; Fabrizio Nelli; Maria Rita Migliorino; Olga Martelli; Enrico πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objective of the current study was to define the activity and tolerability, as well as the influence on resectability, of the combination of gemcitabine, paclitaxel, and cisplatin (GTP) as induction chemotherapy for patients with Stage IIIA(N2) nonsmall cell lung carc

Alternating chemotherapy with etoposide
Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group
✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor